Moderate acceptance of COVID-19 vaccination in patients pre- and post-heart transplantation: Experiences from a German Transplant Centre [0.03%]
德国移植中心心脏移植前后患者对COVID-19疫苗接种的接受度调查
Daniel Oehler,Raphael Romano Bruno,Udo Boeken et al.
Daniel Oehler et al.
Introduction and objectives: Patients awaiting heart transplantation (HTx) are at increased risk developing severe coronavirus disease 2019 (COVID-19). Patients supported by a left ventricular assist device (LVAD) face ad...
First report of sexually transmitted primary cytomegalovirus proctocolitis in a renal transplant recipient [0.03%]
首例肾移植受者性传播原发巨细胞病毒前列腺炎报告
John I Hogan,Kevin L Steiner,Costi D Sifri
John I Hogan
Treatment outcomes of nontuberculous mycobacterial pulmonary disease in lung transplant recipients [0.03%]
肺移植受者的非结核分枝杆菌肺病的治疗效果
Takashi Hirama,Lianne G Singer,Sarah K Brode et al.
Takashi Hirama et al.
Background: Lung transplant (LTX) recipients are at risk miscellaneous infections, among whom the clinical significance of nontuberculous mycobacteria (NTM) is increasingly recognized. Despite anti-mycobacterial therapy b...
Changes in cytomegalovirus-specific T-cell immunity with immunomodulation in serodiscordant high-risk transplant recipients [0.03%]
器官移植高危受捐者中人类巨细胞病毒特异性T细胞免疫随免疫调节的变化而变化
Tyler Tinkham,Chelsey Chenxi Song,Ryan Winstead et al.
Tyler Tinkham et al.
Intestinal mucormycosis initially identified by next-generation sequencing of cell-free DNA [0.03%]
基于细胞游离DNA的二代测序技术最初识别肠道黏膜曲霉病
Rachel Martin-Blais,Saumya Pathak,Sean Fitzwater et al.
Rachel Martin-Blais et al.
Mucormycosis is a rare fungal infection that typically affects severely immunocompromised individuals, often resulting in significant morbidity and mortality. Although early and aggressive intervention is necessary to prevent poor outcomes,...
Long-term effects of COVID-19 in solid organ transplantation recipients [0.03%]
COVID-19对固有器官移植受者长期影响
Maria Larrosa-Garcia,Sonia Garcia-Garcia,Ibai Los-Arcos et al.
Maria Larrosa-Garcia et al.
Comparing posaconazole and itraconazole for antifungal prophylaxis in critically ill lung transplant recipients: Efficacy and plasma concentrations [0.03%]
比较泊沙康唑与伊曲康唑用于重症肺移植受者的抗真菌预防的疗效及血药浓度
Simon Kallee,Christina Scharf,Ines Schroeder et al.
Simon Kallee et al.
Background: Posaconazole and itraconazole are commonly used for systemic antifungal prophylaxis after lung transplantation. The aim of this study on critically ill lung transplant recipients was to assess the rate of adeq...
Impact of anti-anaerobic antibiotic activity on graft-versus-host disease in allogeneic hematopoietic stem cell transplant (HSCT) recipients at an institution that utilizes antibiotic cycling [0.03%]
在一个使用抗生素轮换的机构中评估受体抗厌氧菌抗生素活性对同种异体造血干细胞移植后移植物抗宿主病的影响
Christine R Hanks,Douglas Slain,Abraham S Kanate et al.
Christine R Hanks et al.
Background: At our institution, antibiotic cycling for febrile neutropenia is utilized to increase heterogeneity of antibiotic exposure in patients who have undergone an allogeneic hematopoietic stem cell transplantation ...
Characteristics and outcomes among lung transplant patients with respiratory syncytial virus infection [0.03%]
呼吸道合胞病毒感染肺移植患者的临床特点及转归分析
Luke D Mahan,April Points,Manish R Mohanka et al.
Luke D Mahan et al.
Background: To describe characteristics and outcomes among lung transplantation (LT) patients with respiratory syncytial virus (RSV) infection and elucidate the predictors of 1-year survival after RSV infection. ...
Early post-liver transplantation infections and their effect on long-term survival [0.03%]
早期肝移植感染与长期存活的关系
Yaara Leibovici-Weissman,Noa Anchel,Eviatar Nesher et al.
Yaara Leibovici-Weissman et al.
Background: Infections post-liver transplantation are major drivers for morbidity and mortality. However, the impact of infections within 180 days post-liver transplantation on long-term survival is not clear. ...